[Theopek in the treatment of patients with obstructive diseases of the respiratory organs].
Data are reported on the high clinical and broncholytic efficacy of a new native preparation of theophylline of prolonged action--theopek. The drug is well tolerated by the patients, reduces the necessity in broncholytics and glucocorticosteroids and is recommended for basis therapy of patients with obstructive diseases of the respiratory organs.